Survey: 5% of healthcare leaders think Trump will take 'meaningful' action on drug prices

While a majority of healthcare leaders believe President Donald Trump's administration will take action to lower drug prices, few think these measures will be "meaningful," according to a new survey from Venrock.

Venrock polled 274 executives from health IT startups, insurers, providers and more, to gauge their predictions for future of the healthcare industry.

One survey question asked respondents if the administration will lower drug prices over the next four years.

Here is a breakdown of the responses, as reported by Axios.

1. Drug prices will see meaningful decreases: 5 percent

2. Drug prices will see marginal decreases: 49 percent

3. Drug prices will fall voluntarily in response to public concerns: 19 percent

4. Drug prices will not decrease: 27 percent

To view the full report, click here.

More articles on supply chain:

FedEx launches first customer-facing robot
Harvoni, Sovaldi approved for pediatric patients
Survey: 26% of supply chain leaders considering self-distribution

Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars